SGLT-2 Inhibitors: Renal and Cardiovascular Benefits

Authors

Muhammad Hashaam Arshad, Rochester Regional HealthFollow

Document Type

Presentation

Department

Internal Medicine

Abstract

Agenda

• Mechanism of action
• Glycemic control
• Renal benefits
• Cardiovascular benefits
• Serious adverse effects

Publication Date

5-14-2020

Comments

00:02:26 Annual Joseph D. Cappuccio, MD Memorial Lecture

00:10:22 SGLT-2 Inhibitors: Renal and Cardiovascular Benefits

Recommended Citation

Arshad, M. H. (2020). SGLT-2 Inhibitors: Renal and Cardiovascular Benefits. Retrieved from https://scholar.rochesterregional.org/grandrounds_rgh/56